In contrast, in the malignant mesothelioma cell line panel, CCL2 expression was downregulated compared to the marked increase in CXCR2-dependent chemokines, IL-1α, and VEGF-A underscoring the critical role played by cell type in the context of arginine deprivation therapy. This evidence concerns the gene CCL2 and malignant mesothelioma.